Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP410138.RA09xlFk0pjuc8nirePQHjh0hGByHoc3-SH8dKw_0UPnA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP410138.RA09xlFk0pjuc8nirePQHjh0hGByHoc3-SH8dKw_0UPnA130_assertion type Assertion NP410138.RA09xlFk0pjuc8nirePQHjh0hGByHoc3-SH8dKw_0UPnA130_head.
- NP410138.RA09xlFk0pjuc8nirePQHjh0hGByHoc3-SH8dKw_0UPnA130_assertion description "[Sixty-one transplanted patients who had IgAN as an original disease (30 with biopsy-proved early recurrence, median 2.9 yr post-transplant), and 120 controls, were investigated for aberrantly glycosylated IgA1, IgA binding to mesangial matrix, macromolecular IgA (IgA/fibronectin and uteroglobulin/IgA/fibronectin complexes), and polymorphisms of cytokines [tumor necrosis factor alpha (TNFalpha), interleukin 10 (IL-10), IL-6, interferon gamma and transforming growth factor beta 1] and renin-angiotensin system (angiotensinogen converting enzyme, angiotensin II receptor 1, and angiotensinogen) genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410138.RA09xlFk0pjuc8nirePQHjh0hGByHoc3-SH8dKw_0UPnA130_provenance.
- NP410138.RA09xlFk0pjuc8nirePQHjh0hGByHoc3-SH8dKw_0UPnA130_assertion evidence source_evidence_literature NP410138.RA09xlFk0pjuc8nirePQHjh0hGByHoc3-SH8dKw_0UPnA130_provenance.
- NP410138.RA09xlFk0pjuc8nirePQHjh0hGByHoc3-SH8dKw_0UPnA130_assertion SIO_000772 17988266 NP410138.RA09xlFk0pjuc8nirePQHjh0hGByHoc3-SH8dKw_0UPnA130_provenance.
- NP410138.RA09xlFk0pjuc8nirePQHjh0hGByHoc3-SH8dKw_0UPnA130_assertion wasDerivedFrom befree-20150227 NP410138.RA09xlFk0pjuc8nirePQHjh0hGByHoc3-SH8dKw_0UPnA130_provenance.
- NP410138.RA09xlFk0pjuc8nirePQHjh0hGByHoc3-SH8dKw_0UPnA130_assertion wasGeneratedBy ECO_0000203 NP410138.RA09xlFk0pjuc8nirePQHjh0hGByHoc3-SH8dKw_0UPnA130_provenance.